Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories.
To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
----------------------------------------------
** BREAST CANCER News **
No news for this category today.
----------------------------------------------
** CANCER / ONCOLOGY News **
Indiana Health Industry Forum To Hold Cancer/Oncology Summit
http://www.medicalnewstoday.com/articles/125292.php
Indiana institutions, companies and individuals with a common interest in cancer research, diagnosis and treatment will gather at a cancer/oncology summit Dec. 1-2 at the University Place Conference Center, IUPUI, in Indianapolis.
CEO Roundtable On Cancer Offers "Common Language" To Jump Start Cancer Clinical Trials
http://www.medicalnewstoday.com/articles/125268.php
Potentially life-lengthening cancer therapies could enter clinical trials and ultimately reach cancer patients dramatically faster thanks to legal contract language created by the CEO Roundtable on Cancer, a nonprofit group of cancer-fighting CEOs.
Lifestyle And Testicular Dysfunction: A Brief Update
http://www.medicalnewstoday.com/articles/125233.php
UroToday.com - A variety of testicular pathologies to include testicular cancer, cryptorchidism and defective spermatogenesis have been increasing. While genetic factors play a role, growing evidence suggests that the testicle is damaged by environment and lifestyle-related factors either prenatally or at puberty.
Laser Photoablation Of Renal Pelvic Tumours
http://www.medicalnewstoday.com/articles/125232.php
BERKELEY, CA (UroToday.com) - This is a case series describing the use of a dual wavelength (wavelength shifted) Neodymium:Yttrium Aluminum Garnet (Nd:YAG) laser used for renal sparing surgery to treat transitional cell carcinoma of the renal pelvis.
----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **
One In Four Teenage Girls Received HPV Vaccine In Its First Full Year Of Distribution, CDC Says
http://www.medicalnewstoday.com/articles/125175.php
<BR />A report released by <A href="http://www.cdc.gov/" target=_new>CDC</A> on Thursday said 25% of teenage girls in the U.S. between ages 13 and 17 received at least one dose of <A href="http://www.
----------------------------------------------
** COLORECTAL CANCER News **
Is CT-Colonoscopy A Valuable Tool To Detect Colorectal Cancer?
http://www.medicalnewstoday.com/articles/125210.php
CTC (virtual colonoscopy) is a thin slice CT scan of the abdomen after adequate bowel preparation and colon insufflation in which data are reconstructed providing axial, multiplanar, and endoluminal views, in order to visualize internal colonic wall.
----------------------------------------------
** LUNG CANCER News **
No news for this category today.
----------------------------------------------
** LYMPHOMA / LEUKEMIA News **
No news for this category today.
----------------------------------------------
** PROSTATE / PROSTATE CANCER News **
FDA Approves Rapaflo For The Treatment Of Symptoms Due To An Enlarged Prostate Gland
http://www.medicalnewstoday.com/articles/125281.php
The U.S. Food and Drug Administration today approved Rapaflo (silodosin) capsules for the treatment of symptoms due to benign prostatic hyperplasia (BPH), a condition also known as an enlarged prostate.
Single NX-1207 Dose Significantly Improved BPH Symptom Scores And Significantly Reduced Prostate Size After 90 Days
http://www.medicalnewstoday.com/articles/125256.php
Nymox Pharmaceutical Corporation (NASDAQ: NYMX) is please to announce that the presentation of NX-1207 clinical study data at the AUA South Central Section annual meeting in Santa Ana Pueblo, NM was featured in the <i>Urology Times</i>, the widely distributed and most read publication of U.
The Case For Prostate-Specific Antigen Screening Starting At Age 40
http://www.medicalnewstoday.com/articles/125251.php
UroToday.com - Dr. Robert Nadler, of Northwestern University, wrote an excellent editorial in a recent issue of <i>Cancer</i> regarding the commencement of prostate cancer (CaP) screening at age 40.
Testosterone Therapy In Hypogonadal Men And Potential Prostate Cancer Risk: A Systematic Review
http://www.medicalnewstoday.com/articles/125250.php
UroToday.com - In the online edition of the <i>International Journal of Impotence Research</i>, Dr. R. Shabsigh and his associates presented a systematic review of testosterone therapy for hypogonadism and its relation to prostate cancer (CaP).
Long-Term Assessment Of Prostate Cancer Progression Free Survival
http://www.medicalnewstoday.com/articles/125249.php
UroToday.com - In the online version of The Prostate, Dr. Robert W. Veltri and his colleagues from Johns Hopkins University reported on the correlation of molecular pathways and progression-free survival (PFS) in prostate cancer (CaP).
Approval From The Swedish Medical Products Agency To Start A Clinical Trial Using A Xenogenic PSA DNA Vaccine
http://www.medicalnewstoday.com/articles/125246.php
Cyto Pulse Sciences, a leading producer of electric field based, intradermal DNA Vaccine delivery systems, today announced approval by Swedish regulatory authorities to begin a Phase I/II study of DNA vaccination in patients with recurring prostate cancer.
Transcorporal Artificial Urinary Sphincter Placement For Incontinence In High-risk Patients After Treatment Of Prostate Cancer
http://www.medicalnewstoday.com/articles/125235.php
UroToday.com - Our single center observational cohort study sought to examine the indications for the usage of transcorporal placement of artificial urinary sphincter (AUS) for incontinence after treatment for prostate adenocarcinoma.
Sexually Transmissible Infections And Prostate Cancer Risk
http://www.medicalnewstoday.com/articles/125234.php
UroToday.com - Circulating antibodies against infectious agents and self-reported history of syphilis and gonorrhea represent an individual's cumulative lifetime exposure or past infections, and thus are particularly suited for risk evaluation of cancer with a long latent disease process.
-------------------------------------------------------------
You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
No comments:
Post a Comment